U.S. flag

An official website of the United States government

NM_001161586.3(ME3):c.1660G>A (p.Asp554Asn) AND Inborn genetic diseases

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Feb 10, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002968688.1

Allele description [Variation Report for NM_001161586.3(ME3):c.1660G>A (p.Asp554Asn)]

NM_001161586.3(ME3):c.1660G>A (p.Asp554Asn)

Gene:
ME3:malic enzyme 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q14.2
Genomic location:
Preferred name:
NM_001161586.3(ME3):c.1660G>A (p.Asp554Asn)
HGVS:
  • NC_000011.10:g.86441434C>T
  • NM_001014811.2:c.1660G>A
  • NM_001161586.3:c.1660G>A
  • NM_001351934.2:c.1660G>A
  • NM_001395868.1:c.1653+1387G>A
  • NM_006680.3:c.1660G>A
  • NP_001014811.1:p.Asp554Asn
  • NP_001155058.1:p.Asp554Asn
  • NP_001338863.1:p.Asp554Asn
  • NP_006671.2:p.Asp554Asn
  • NC_000011.9:g.86152476C>T
  • NM_001161586.1:c.1660G>A
  • NR_147828.2:n.1958G>A
  • NR_147829.2:n.2378G>A
  • NR_147830.2:n.1931G>A
  • NR_147831.2:n.2288G>A
  • NR_172888.1:n.1967G>A
  • NR_172889.1:n.1891G>A
Protein change:
D554N
Molecular consequence:
  • NM_001395868.1:c.1653+1387G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001014811.2:c.1660G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001161586.3:c.1660G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351934.2:c.1660G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006680.3:c.1660G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_147828.2:n.1958G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_147829.2:n.2378G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_147830.2:n.1931G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_147831.2:n.2288G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_172888.1:n.1967G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_172889.1:n.1891G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
1

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003690640Ambry Genetics
criteria provided, single submitter

(Ambry General Variant Classification Scheme_2022)
Uncertain significance
(Feb 10, 2022)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing

Details of each submission

From Ambry Genetics, SCV003690640.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

The c.1660G>A (p.D554N) alteration is located in exon 15 (coding exon 14) of the ME3 gene. This alteration results from a G to A substitution at nucleotide position 1660, causing the aspartic acid (D) at amino acid position 554 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

Last Updated: Feb 13, 2023